BioCatalyst

PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation — catalyst calendar

1 verified catalyst event(s) referencing PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-23
in 2mo
ESTIMATED
 READOUT
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination Wit
Phase 1/2 · Breast Cancer, Solid Tumors
 PFE PFIZER INC PF-07220060 + PF-07104091 combination do ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.